Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found four records

$5,000.00

May 22, 2026

For-profit organization

Agreement:

Canada–UK Biomanufacturing Peer to Peer In Person Networking Meetings – June 2026

Agreement Number:

1043948

Duration: from May 22, 2026 to Jun 19, 2026
Description:

Participation in Canada–UK biomanufacturing peer-to-peer networking meetings – June 8 to 15, 2026. Through the 2023 Canada–UK Biomanufacturing Initiative (Memorandum of Cooperation), Canada and the United Kingdom committed to advancing collaboration in biomanufacturing, with a focus on co-innovation, workforce development, and scale-up. The initiative includes the creation of a bilateral peer-to-peer network that brings together experts and organizations from both countries to strengthen partnerships and pursue shared growth opportunities.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program
Location: Mississauga, Ontario, CA L5K 1A9

$150,000.00

Jul 1, 2025

For-profit organization

Agreement:

Continuous Flow (CF) technology in manufacture and commercialization of API(s) and advanced intermediates for pharmaceutical market.

Agreement Number:

1031472

Duration: from Jul 1, 2025 to Mar 31, 2026
Description:

This project consists of implementation of Continuous Flow technology into manufacturing processes for production of pharmaceutical materials (e.g. active pharmaceutical ingredients,). The project objectives are to intensify manufacturing processes, improve safety, and reduce manufacturing costs and carbon footprints.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Mississauga, Ontario, CA L5K 1A9

$499,520.00

Apr 1, 2025

For-profit organization

Agreement:

UK Biomanufacturing - 10136110 - NextGen ADC Platform-Engineering High-Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production

Agreement Number:

1030116

Duration: from Apr 1, 2025 to Mar 30, 2027
Description:

The project brings together the expertise from Daresbury Proteins Ltd ("Daresbury"), a United Kingdom-based company specializing in novel expression platforms, the NRC and Eurofins CDMO Alphora Inc. ("Alphora").

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Mississauga, Ontario, CA L5K 1A9

$22,439,200.00

Jan 4, 2023

For-profit organization

Agreement:

CDMO Biologics Development and Manufacturing operation

Agreement Number:

819623

Duration: from Jan 4, 2023 to Jan 1, 2046
Description:

This project will support the establishment of a biomanufacturing and development facility that is focused on mammalian cell culture. The facility will manufacture and produce antibody-based therapeutics and other protein biologics.

Organization: Innovation, Science and Economic Development Canada
Program Name: SIF Stream2- Growth
Location: Mississauga, Ontario, CA L5K1B3